Alison Hannah, M.D.
Board Member
Rigel Pharmaceuticals Inc (RIGL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alison Hannah, M.D.
Alison Hannah, M.D. is recorded as Board Member at Rigel Pharmaceuticals Inc (RIGL). Rigel Pharmaceuticals Inc reported in an 8-K filed May 20, 2026 that Alison Hannah, M.D. was appointed Director, effective May 14, 2026.
“Each of the nominees for director, to serve until the Company's 2029 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified, was elected as follows:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rigel Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Raul R. Rodriguez CEO, Board Member
- Raul Rodriguez CEO, Board Member
- Dean Schorno CFO
- Raymond Furey General Counsel
- Alison Hannah Board Member
- Alison L. Hannah Board Member
- Brian L. Kotzkin Board Member
- Gary A. Lyons Board Member
- Gregg A. Lapointe Board Member
- Jane Wasman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.